NASDAQ:ADUSAddus Homecare Stock Price, Forecast & News

Addus Homecare's stock was trading at $67.64 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ADUS shares have increased by 37.5% and is now trading at $92.98. View which stocks have been most impacted by Coronavirus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Addus Homecare in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Addus Homecare.

Addus Homecare is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Addus Homecare.

Addus Homecare Co. (NASDAQ:ADUS) issued its quarterly earnings results on Monday, May, 4th. The company reported $0.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.56 by $0.13. The firm had revenue of $190.20 million for the quarter, compared to analyst estimates of $181.08 million. Addus Homecare had a net margin of 3.35% and a return on equity of 8.00%. View Addus Homecare's earnings history.

Addus Homecare updated its first quarter 2020 After-Hours earnings guidance on Monday, May, 4th. The company provided earnings per share guidance of 0.77-0.77 for the period, compared to the Thomson Reuters consensus estimate of $0.63. The company issued revenue guidance of $190.2-190.2 million, compared to the consensus revenue estimate of $179.06 million.

8 analysts have issued 1-year price objectives for Addus Homecare's shares. Their forecasts range from $85.00 to $107.00. On average, they expect Addus Homecare's stock price to reach $96.29 in the next twelve months. This suggests a possible upside of 3.6% from the stock's current price. View analysts' price targets for Addus Homecare.

Media headlines about ADUS stock have trended neutral this week, according to InfoTrie Sentiment. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Addus Homecare earned a media sentiment score of 0.1 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutAddus Homecare.

Some companies that are related to Addus Homecare include Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), Option Care Health (OPCH) and New York Health Care (BBAL). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus Homecare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), Cisco Systems (CSCO), CVS Health (CVS), Ulta Beauty (ULTA), Alibaba Group (BABA) and Walt Disney (DIS).

Addus Homecare trades on the NASDAQ under the ticker symbol "ADUS."

Addus Homecare's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (12.78%), TimesSquare Capital Management LLC (4.57%), Invesco Ltd. (4.00%), State Street Corp (2.65%), Principal Financial Group Inc. (2.47%) and Cloverdale Capital Management LLC (2.31%). Company insiders that own Addus Homecare stock include Brian Poff, Darby Anderson, David W Tucker, Eos Capital Partners Iii L P, James Zoccoli, Laurie Manning, Mark L First, R Dirk Allison, Sean Gaffney, Susan T Weaver and W Bradley Bickham. View institutional ownership trends for Addus Homecare.

ADUS stock was sold by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, Castleark Management LLC, THB Asset Management, BlackRock Inc., TimesSquare Capital Management LLC, Russell Investments Group Ltd., Victory Capital Management Inc., and Victory Capital Management Inc.. Company insiders that have sold Addus Homecare company stock in the last year include Brian Poff, Darby Anderson, David W Tucker, Laurie Manning, Mark L First, R Dirk Allison, Sean Gaffney, Susan T Weaver, and W Bradley Bickham. View insider buying and selling activity for Addus Homecare.

ADUS stock was purchased by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Cloverdale Capital Management LLC, Eaton Vance Management, JPMorgan Chase & Co., Nuveen Asset Management LLC, State Street Corp, Silvercrest Asset Management Group LLC, and Geode Capital Management LLC. View insider buying and selling activity for Addus Homecare.

Shares of ADUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ADUS stock can currently be purchased for approximately $92.98.

Addus Homecare has a market capitalization of $1.45 billion and generates $518.12 million in revenue each year. Addus Homecare employs 33,153 workers across the globe.

The official website for Addus Homecare is www.addus.com.

Addus Homecare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The company can be reached via phone at 469-535-8200 or via email at [email protected]